Waaree Renewable Technologies (NSE: WAAREERTL) adds battery storage and solar contracts, but will margins recover?
Read More Pharma Industry News Novartis’ remibrutinib shows promising results in Phase III studies for chronic spontaneous urticaria Novartis has revealed encouraging data from the Phase III REMIX-1 and REMIX-2 studies. The studies focused on remibrutinib,… byPallavi MadhirajuNovember 13, 2023